Does High-frequency Resistance Exercise Offer Additional Benefits to Older Adults? Learnings from a Randomized Controlled Trial
Overview
Affiliations
Objective: Resistance exercise is an effective strategy to improve muscle strength in older adults. A limited-load resistance would be flexible and suitable for community-based training. It was unclear whether high-frequency resistance exercise offer additional benefits to older adults. Here, we aimed to examine the effect of limited-load resistance exercise among different frequency on muscle parameters in older adults.
Methods: The current study was a single-blind, randomized controlled trial comparing the effectiveness of different-frequency resistance exercise in older adults. Change in skeletal muscle was estimated with a multi-frequency bioelectrical impedance analyzer. Demographics, physical examination, nutritional assessment, prealbumin and lymphocytes were also measured. Fisher's precision probability test and baseline-adjusted generalized linear models were applied accordingly to analyze the influence of dose-different exercise on prevalence of sarcopenia, muscle parameters and body composition. A two-sided p value of < 0.05 was defined statistical significance.
Results: The participants had a mean age of 71.96 years and close gender ratio. One hundred and twenty-seven participants (control 40; low-dose 46; high-dose 41) completed the 6-month exercise intervention. In contrast to control group, only high-dose exercise groups experienced improvements in muscle mass (0.66 kg, p < 0.001) and max grip strength (+ 2.17 kg, p < 0.001). There were significant dose-response effects of muscle mass (index), fat mass (index), max grip strength, 5-times sit to stand test, 6-minute walking test and visceral fat area (all p <0.01).
Conclusions: As the proved dose-dependent effect, current findings supported high-frequency limited-load resistance exercise applied and extended among older adults in community.
Trial Registration: This study was registered at Chinese Clinical Trial Registry Network (ChiCTR2200062007, Registered on 19 July 2022).
Dai L, Tang Y, Guo Y, Lai X, Wang X, Li B BMC Geriatr. 2025; 25(1):131.
PMID: 40012051 PMC: 11863621. DOI: 10.1186/s12877-025-05802-2.
Sun Y, Yang S, Xiao Z, An Y, Zhao H Sci Rep. 2025; 15(1):6953.
PMID: 40011668 PMC: 11865546. DOI: 10.1038/s41598-025-91437-7.